Neuraxis Inc./$NRXS
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Ticker
$NRXS
Sector
Primary listing
AMEX
Employees
21
Headquarters
Website
Neuraxis Inc. Metrics
BasicAdvanced
$30M
-
-$1.01
3.16
-
Price and volume
Market cap
$30M
Beta
3.16
52-week high
$6.20
52-week low
$1.33
Average daily volume
748K
Financial strength
Current ratio
1.585
Quick ratio
1.425
Long term debt to equity
10.486
Total debt to equity
21.799
Interest coverage (TTM)
-145.60%
Profitability
EBITDA (TTM)
-6.907
Gross margin (TTM)
84.35%
Net profit margin (TTM)
-224.24%
Operating margin (TTM)
-206.68%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
-125.53%
Return on equity (TTM)
-3,071.15%
Valuation
Price to revenue (TTM)
6.817
Price to book
12.05
Price to tangible book (TTM)
13.76
Price to free cash flow (TTM)
-3.649
Free cash flow yield (TTM)
-27.41%
Free cash flow per share (TTM)
-0.762
Growth
Revenue change (TTM)
36.89%
Earnings per share change (TTM)
-22.88%
3-year revenue growth (CAGR)
9.82%
3-year earnings per share growth (CAGR)
-32.15%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neuraxis Inc. stock?
Neuraxis Inc. (NRXS) has a market cap of $30M as of December 01, 2025.
What is the P/E ratio for Neuraxis Inc. stock?
The price to earnings (P/E) ratio for Neuraxis Inc. (NRXS) stock is 0 as of December 01, 2025.
Does Neuraxis Inc. stock pay dividends?
No, Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders as of December 01, 2025.
When is the next Neuraxis Inc. dividend payment date?
Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuraxis Inc.?
Neuraxis Inc. (NRXS) has a beta rating of 3.16. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.